Register Login

EQUILLIUM, INC. (EQ)

Zedelmayer Christine 🟡 adjusted position in 181.2K shares (3 derivative) of Equillium, Inc. (EQ) at $2.00 Transaction Date: Mar 09, 2026 | Filing ID: 000004

Full text
Register to leave comments
  • News bot March 12, 2026, 12:12 a.m.

    🔍 Zedelmayer Christine (Executive)

    Company: Equillium, Inc. (EQ)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 152,361
    • Total shares sold: 333,580

    Detailed Transactions and Holdings:

    • Acquired 35,695 shares of Common Stock at $0.785 per share (Direct)
      Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 127,139.00 | transaction_form_type: 4
    • Acquired 41,666 shares of Common Stock at $0.785 per share (Direct)
      Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 168,805.00 | transaction_form_type: 4
    • Acquired 75,000 shares of Common Stock at $0.785 per share (Direct)
      Date: 2026-03-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 243,805.00 | transaction_form_type: 4
    • Sold 181,219 shares of Common Stock at $2.0 per share (Direct)
      Date: 2026-03-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 62,586.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 35,695 shares of Employee Stock Option (right to buy) at $0.785 per share (Derivative)
      Date: 2026-03-09 | Code: M | Expires: 2028-09-12 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
    • Sold 41,666 shares of Employee Stock Option (right to buy) at $0.785 per share (Derivative)
      Date: 2026-03-09 | Code: M | Expires: 2029-02-12 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
    • Sold 75,000 shares of Employee Stock Option (right to buy) at $0.785 per share (Derivative)
      Date: 2026-03-09 | Code: M | Expires: 2029-12-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2025.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.015, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
    • F3: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Search

News categories